Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compounds inhibiting leucine-rich repeat kinase enzyme activity

Compounds inhibiting leucine-rich repeat kinase enzyme activity

US Patent 9718818 · Granted Aug 1, 2017

Estimated economic value: $68,609,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

AAV capsids for targeting nervous system and uses thereof2025
Hepatitis B antiviral agents2025
Spiropyrrolidine derived antiviral agents2025
Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine recept2025
Manufacture of compounds and compositions for inhibiting the activity of SHP22025
C-terminal SRC kinase inhibitors2025
Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine recept2025
Macrocyclic spiropyrrolidine derived antiviral agents2025
Thyroid hormone receptor agonists2025
Metabolically stable pyrimidinyl dihydroquinoxalinones as tubulin polymerization2025
Recombinant adeno-associated viral vectors for treating Bietti Crystalline Dystr2025
Biodegradable ultra-pH sensitive polymers2025